洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR1900028695】Recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong

基本信息
登记号

ChiCTR1900028695

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2019-12-31

临床申请受理号

/

靶点

/

适应症

schizophrenia

试验通俗题目

Recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong

试验专业题目

The effectiveness of a professionally-facilitated recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong: A comparison to a peer-led peer support programme

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

This study primarily intends to evaluate the effectiveness and differential benefits of two recovery models, namely, professionally-facilitated recovery-oriented cognitive-behaviour approach (ROCBA) and a peer-led peer support programme (PSP), which have shown initial promising results for Chinese people with schizophrenia in Hong Kong.

试验分类
试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

A research assistant who is blind to the research design will generate the random number sequence for randomization. A series of block sequence following mixed block sizes (the lock size can be three and six) to assign sample numbers equally to each group. And then randomize the possible sequences block

盲法

Open label

试验项目经费来源

General Research Fund (GRF) of the University Grants Committee of the HKSAR

试验范围

/

目标入组人数

50

实际入组人数

/

第一例入组时间

2020-01-01

试验终止时间

2020-12-31

是否属于一致性

/

入选标准

(1) Chinese adults aged 18 to 65 years; (2) able to understand Cantonese or Chinese; (3) have a diagnosis of DSM-V schizophrenia or schizophrenia spectrum disorders; (4) currently experiencing a low level of functioning above 10 as indicated by SFQ scores, and (5) compliant to medications.;

排除标准

Exclusion criteria include neurological disease or damage that would compromise cognitive functioning, physical handicaps that would interfere with assessment procedures or therapy attendance, and/or suicidal attempts or ideation in the past three months.;

研究者信息
研究负责人姓名
试验机构

香港大學

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

香港大學的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品